Calyxt Inc Stock News

Wall Street securities analysts on Friday revised their ratings and price targets on several U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings. HIGHLIGHTS

Shares of Calyxt (NASDAQ:CLXT) were unchanged in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 47.83% year over year to ($0.34), which missed

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the first quarter ended March 31, 2020.

Bank of New York Mellon Corp lessened its holdings in shares of Calyxt Inc (NASDAQ:CLXT) by 25.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched a retail offering of Calyno® cooking oil, the company’s first commercial product, a premium, high-performing oil, through

Zacks Investment Research upgraded shares of Calyxt (NASDAQ:CLXT) from a hold rating to a buy rating in a research note released on Monday morning, Zacks.com reports. Zacks Investment Research current

Calyxt (NASDAQ:CLXT) is scheduled to announce its earnings results before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter.

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Analysts forecast that Calyxt Inc (NASDAQ:CLXT) will report ($0.33) earnings per share for the current quarter, Zacks reports. Zero analysts have made estimates for Calyxt’s earnings. Calyxt reporte

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discu

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential t

It’s easy to talk about gene editing and genetic modification in terms that sound like science fiction. But as much as that may drive clicks for media sensationalists, it does more harm than good fo

Wall Street brokerages predict that Calyxt Inc (NASDAQ:CLXT) will announce ($0.33) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the ‘Power and Possibilities of Plants’.